3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Neoplasms
41
Breast Neoplasms
40
Lung Neoplasms
25
Carcinoma, Non-Small-Cell Lung
20
Colorectal Neoplasms
19
Uterine Cervical Neoplasms
13
Prostatic Neoplasms
13
Head and Neck Neoplasms
11
Carcinoma, Hepatocellular
11
Pancreatic Neoplasms
10
Melanoma
10
Ovarian Neoplasms
9
Neoplastic Cells, Circulating
7
Myelodysplastic Syndromes
7
Glioma
7
Esophageal Neoplasms
7
Endometrial Neoplasms
7
Brain Neoplasms
7
Sarcoma
6
Multiple Myeloma
6
Gastrointestinal Neoplasms
6
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
5
Leukemia, Myeloid, Acute
5
Disease
5
Colonic Neoplasms
5
Uveal Melanoma
4
Skin Neoplasms
4
Neoplasm, Residual
4
Interventions
Specimen Handling
9
Magnetic Resonance Spectroscopy
6
Biopsy
6
pembrolizumab
3
X-Rays
3
Nivolumab
3
olaparib
2
durvalumab
2
ceralasertib
2
Paclitaxel
2
Immunoglobulin G
2
Carboplatin
2
trastuzumab deruxtecan
1
sargramostim
1
ribociclib
1
pelcitoclax
1
cobimetinib
1
cediranib
1
capivasertib
1
cabozantinib
1
atezolizumab
1
Tissue Banks
1
Taxes
1
TIC10 compound
1
Radiation
1
Phantoms, Imaging
1
Minimally Invasive Surgical Procedures
1
Ipilimumab
1
Indocyanine Green
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Blood Specimen Collection
×
1 year
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled